Effects of intermittent fasting on blood pressure, serum lipid profile and glucose – A review of clinical and experimental evidence.

Q2 Medicine

Obesity Medicine Pub Date : 2024-03-01 DOI:10.1016/j.obmed.2024.100539

Siti Qusyasyiah Ahmad Suhaimi , Siti Safiah Mokhtar , Aida Hanum G Rasool

{"title":"Effects of intermittent fasting on blood pressure, serum lipid profile and glucose – A review of clinical and experimental evidence.","authors":"Siti Qusyasyiah Ahmad Suhaimi , Siti Safiah Mokhtar , Aida Hanum G Rasool","doi":"10.1016/j.obmed.2024.100539","DOIUrl":null,"url":null,"abstract":"<div><p>Cardiovascular disease (CVD) is the leading cause of death worldwide. Lifestyle modification is at the forefront of CVD disease prevention. Lifestyle modification includes taking steps to increase physical activity and practising a healthy, balanced diet to lower risk factors for developing CVD. Intermittent fasting (IF) has increasingly become popular among subjects wanting to lose weight and maintain a healthy weight; it has also been reported to be associated with other health benefits as well. IF is an eating plan that alternates between fasting and eating on a regular schedule. Although there are no large, randomised controlled trials directly addressing intermittent fasting and cardiovascular outcomes, existing clinical and animal research suggest that IF may reduce the risk of CVD by improving cardiovascular risk factors. This review aims to introduce the topic of intermittent fasting and examine the effects of IF on CVD risk factors specifically effects on serum lipid profile, blood pressure and blood glucose levels. Results from clinical and animal studies on these risk factors will be reviewed.</p></div>","PeriodicalId":37876,"journal":{"name":"Obesity Medicine","volume":"47 ","pages":"Article 100539"},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2451847624000095","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Cardiovascular disease (CVD) is the leading cause of death worldwide. Lifestyle modification is at the forefront of CVD disease prevention. Lifestyle modification includes taking steps to increase physical activity and practising a healthy, balanced diet to lower risk factors for developing CVD. Intermittent fasting (IF) has increasingly become popular among subjects wanting to lose weight and maintain a healthy weight; it has also been reported to be associated with other health benefits as well. IF is an eating plan that alternates between fasting and eating on a regular schedule. Although there are no large, randomised controlled trials directly addressing intermittent fasting and cardiovascular outcomes, existing clinical and animal research suggest that IF may reduce the risk of CVD by improving cardiovascular risk factors. This review aims to introduce the topic of intermittent fasting and examine the effects of IF on CVD risk factors specifically effects on serum lipid profile, blood pressure and blood glucose levels. Results from clinical and animal studies on these risk factors will be reviewed.

查看原文本刊更多论文

间歇性禁食对血压、血脂和血糖的影响--临床和实验证据综述。

心血管疾病（CVD）是导致全球死亡的主要原因。改变生活方式是预防心血管疾病的首要任务。生活方式的改变包括采取措施增加体育锻炼和实行健康、均衡的饮食，以降低患心血管疾病的风险因素。间歇性禁食（IF）越来越受到希望减肥和保持健康体重的人的欢迎；据报道，间歇性禁食还与其他健康益处有关。间歇性禁食是一种在禁食和按时进食之间交替进行的饮食计划。虽然目前还没有直接针对间歇性禁食和心血管后果的大型随机对照试验，但现有的临床和动物研究表明，间歇性禁食可通过改善心血管风险因素来降低心血管疾病的风险。本综述旨在介绍间歇性禁食这一主题，并研究间歇性禁食对心血管疾病风险因素的影响，特别是对血清脂质、血压和血糖水平的影响。本文将综述有关这些风险因素的临床和动物研究结果。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Obesity Medicine Medicine-Public Health, Environmental and Occupational Health

CiteScore

5.50

自引率

0.00%

发文量

审稿时长

40 days

期刊介绍： The official journal of the Shanghai Diabetes Institute Obesity is a disease of increasing global prevalence with serious effects on both the individual and society. Obesity Medicine focusses on health and disease, relating to the very broad spectrum of research in and impacting on humans. It is an interdisciplinary journal that addresses mechanisms of disease, epidemiology and co-morbidities. Obesity Medicine encompasses medical, societal, socioeconomic as well as preventive aspects of obesity and is aimed at researchers, practitioners and educators alike.